DUPILUMAB IN PAEDIATRIC PATIENTS WITH EOSINOPHILIC OESOPHAGITIS – DESIGN OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN CHILDREN AGED 1–11 YEARS, WITH ACTIVE EOSINOPHILIC OESOPHAGITIS

Mirna Chehade  1     Evan S. Dellon  2     Marc E. Rothenberg  3     Bin Yao  4     Elizabeth Laws  5     Nikhil Amin  5     Marcella Ruddy  5     Bethany Beazley  5     Kiran Patel  5     Veronica Mas Casullo  5     Jonathan Spergel  6     Leda Mannent  7    
1 Icahn School of Medicine at Mount Sinai, New York, United States
2 University of North Carolina School of Medicine, Chapel Hill, United States
3 Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, United States
4 Regeneron Pharmaceuticals, Inc., Tarrytown, United States
5 Sanofi, Bridgewater, United States
6 Children's Hospital of Philadelphia, Philadelphia, United States
7 Sanofi, Chilly-Mazarin, France

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing